Check out the companies making headlines on Tuesday after the bell:
Atlassian – Shares of the Australian software company were up 1% on revised revenue expectations for the fiscal third quarter. Atlassian now expects sales of between $ 566 million and $ 572 million. Analysts polled by FactSet previously forecast revenue of $ 487.2 million for the company’s third quarter. The new forecast is also above Atlassian’s previous revenue expectations for the quarter.
Stitch Fix – Share of the personal styling service fell 3.2% after the company announced that founder and CEO Katrina Lake will become its executive chairman and Elizabeth Spaulding will take over as CEO, effective August 1.
Endo International – Shares in the pharmaceutical company rose slightly after the company announced promising Phase 3 data on a cellulite treatment was published in the Official Journal of the American Society of Dermatologic Surgery. The data showed that the treatment provides a clinically meaningful improvement in the occurrence of moderate to severe cellulite in the buttocks of adult women compared to placebo.
Amicus Therapeutics – Stocks of the biopharmaceutical company were up 3% after analysts at Cantor Fitzgerald upgraded the stock from neutral to overweight, citing the company’s promising gene therapy results.
Discovery – Discovery’s Class A and Class C shares fell 3.8% and 5.1%, respectively, after CNBC’s David Faber reported that Credit Suisse continues to offload positions in the media company as a result of the Archegos blow Capital Management. Citing traders, Credit Suisse sold 19 million of the media company’s Class A shares and 22 million of Class C shares.